New patent expiration for Galderma Labs drug ORACEA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ORACEA
Annual Drug Patent Expirations for ORACEA

Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.

ORACEA drug price trends.

Drug patent litigation for ORACEA.

This drug has twenty-nine patent family members in thirteen countries.

The generic ingredient in ORACEA is doxycycline. Two suppliers are listed for this compound. Additional details are available on the doxycycline profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top